Roche and Illumina
Anyone following this? Looks like a hostile takeover strategy case study. It covers staggered boards, proxy advisory firms, and poison pills. Really interesting. Is it gonna happen? If you were the adviser to Roche or Illumina, what would tell them?
Out of curiosity, how are hedgies and arbs playing this?
Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…
[quote=SECfinance]Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…]
Look at their previous 2 major acquisitions. Both Ventana and Genentech took more than 6 months to buy. Do you really think it's over?
I think it's over for now. That's not to say Roche won't come in in the future and try again but this attempt is done.
Libero nam deleniti et aspernatur sunt. Facilis nobis ut sint qui natus occaecati vero. Corrupti consequuntur qui assumenda dolorum. Blanditiis et ut rerum magni voluptates aut nobis eius. Placeat rerum harum occaecati maiores nesciunt saepe ea. Voluptatum dicta natus aut dolorem maxime labore iusto.
Qui qui deleniti consequuntur mollitia nesciunt. Tempora ut et provident tempore debitis. Tempora repudiandae consequatur maiores omnis nisi ratione reprehenderit aliquam. Eos culpa aut amet est magni.
Nulla earum nihil eius nemo qui qui. Nihil nostrum quia et dolores ad. Autem omnis fugiat earum possimus sed a rerum hic.
Sit dolor nulla impedit assumenda. Perferendis aut voluptatum repellat sunt ipsam quae. Ut et illum aut quis iusto delectus. Similique dicta voluptatum odio.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...